je.st
news
Tag: biotech
Did Celgene's Billion Dollar Deal With Juno Just Save The Biotech Bull Market?
2015-06-30 16:06:32| Biotech - Topix.net
Steve Brozak is President of WBB Securities, LLC, an investment bank and research firm that specializes in the biotechnology, specialty pharmaceutical and medical device sectors. Mr. Brozak is an award winning analyst whose research has been singled out from his peers for accuracy and performance year after year by the financial industry's most highly regarded rankings organizations.
TSRI and Biotech Partners Find New Antibody Weapons Against Marburg Virus
2015-06-29 19:15:21| Biotech - Topix.net
A new study led by scientists at The Scripps Research Institute identifies new immune molecules that protect against deadly Marburg virus, a relative of Ebola virus. The research provides ingredients needed to develop treatments for future Marburg outbreaks.
Tags: find
partners
virus
weapons
Switzerland's Novartis buys US biotech firm Spinifex
2015-06-29 10:45:54| Biotech - Topix.net
" Swiss drug manufacturer Novartis says it is buying Spinifex Pharmaceuticals, a U.S.-based biotechnology company that specializes in developing treatments for chronic pain. Novartis didn't disclose financial details Monday of the agreement to buy privately held Spinifex, which has its headquarters in Stamford, Connecticut, and an office in Melbourne, Australia.
Tags: firm
biotech
buys
novartis
We're right in the driving seat of the biotech boom
2015-06-28 05:36:30| Biotech - Topix.net
It is said that biotechnology will do for the 21st century what computers did for the 20th century. Technology based on biology is improving our lives.
Biotech Short-Sellers Prefer Amgen To Gilead Sciences
2015-06-28 01:32:55| Biotech - Topix.net
Some of the biggest swings in short interest among the leading biotechs and emerging pharmaceuticals between the May 29 and June 15 settlement dates happened to Amgen, Inc. , Gilead Sciences, Inc. and Illumina, Inc. . Let's take a quick look at how these three stocks have fared recently and what analysts expect from them.
Tags: sciences
prefer
biotech
gilead
Sites : [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] next »